241 — Alibaba Health Information Technology Income Statement
0.000.00%
- HK$74.17bn
- HK$65.34bn
- CNY30.60bn
- 91
- 21
- 81
- 74
Annual income statement for Alibaba Health Information Technology, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15,518 | 20,578 | 26,763 | 27,027 | 30,598 |
Cost of Revenue | |||||
Gross Profit | 3,617 | 4,108 | 5,701 | 5,895 | 7,432 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,076 | 20,781 | 26,218 | 26,075 | 28,971 |
Operating Profit | 442 | -203 | 545 | 951 | 1,627 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 401 | -253 | 551 | 939 | 1,560 |
Provision for Income Taxes | |||||
Net Income After Taxes | 343 | -266 | 537 | 883 | 1,432 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 349 | -266 | 536 | 883 | 1,432 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 349 | -266 | 536 | 883 | 1,432 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.021 | -0.038 | 0.035 | 0.058 | 0.114 |